CureApp
CU
About
CureApp is a Japanese MedTech company that develops and distributes evidence-based Digital Therapeutics (DTx). They specialize in creating software applications classified as medical devices to address conditions where traditional treatments may be insufficient, focusing on behavioral modification and lifestyle changes. Their offerings include prescription DTx apps for conditions like hypertension, nicotine addiction, NASH, and alcohol dependence.
Key facts
At-a-glance profile data
- Website
- cureapp.jp
- Headquarters
- Tokyo, Japan
- Founded
- 2014
- Total funding
- $90M (Series G)
- Business model
- B2B
Funding rounds
Tech stack
Detected on cureapp.jp, last scanned 10 Jun 2026. Run your own scan
- Email provider
- Google Workspace
Add first review
Frequently asked
How much funding has CureApp raised?
CureApp has raised a total of $90M in funding. The most recent round on record is Series G.
What is CureApp's current status?
CureApp's current operating status is: Inactive.